Ubiquinol and mitochondrial health innovation

Mitochondrial health has rapidly evolved from a specialist scientific concept into a commercially relevant platform for brandholders, new product development (NPD) teams and marketers.

The reason is simple: mitochondrial health sits upstream of many health outcomes consumers care about – energy and vitality, healthy ageing, cardiovascular health, cognitive function, fertility and women’s health – making cellular energy and antioxidant protection an attractive, expandable story for product development and portfolio strategy.

Across the European nutraceutical landscape, and globally, interest in longevity and healthy ageing is being reframed through a more mechanistic lens – healthspan rather than lifespan. Healthspan refers to the number of years lived in good health and has become an increasingly important concept in discussions around preventative health and ageing.

According to industry insights provided by Nick Morgan (Founder and Managing Director of Nutrition Integrated), mitochondrial health is increasingly being pulled into the mainstream, driven by a broader cultural shift toward proactive ageing, plus rising consumer familiarity with “how the body works” via the biohacking culture, the Hallmarks of Ageing narrative and ongoing fascination with centenarians living in the Blue Zones.

Brands are responding in two notable ways. First, by widening the innovation aperture beyond capsules and tablets into more accessible, lifestyle-aligned formats such as powders, gummies and functional foods. Second, by sharpening positioning. Rather than trying to own “longevity” broadly, brands are carving out targeted perspectives, led by a category or condition, such as performance, women’s health, cardiometabolic or cognitive health, built on credible mechanisms and substantiated ingredients.

That shift places pressure on ingredient choice. In a category prone to hype, evidence-backed ingredients become central to trust-building and differentiation. As Morgan notes, in an environment dominated by misinformation and quick fixes, clinical substantiation and mechanistic rationale help consumers – and trade customers – feel confident in what they are formulating and buying.

Evolution from supplier to strategic platform-builder

Kaneka Ubiquinol™ business has long been recognised for ingredient manufacturing leadership. What is changing now is how the company shows up for brandholders: not simply as a raw material supplier, but as an innovation partner helping customers translate mitochondrial science into scalable, differentiated products.

This partner framing is visible in how Kaneka supports:

Science-led positioning: Across multiple adjacent health priorities including healthy ageing, women’s health, cardiovascular health, sports performance, cognition and fertility.
Commercial education: Delivered through webinars and technical fact sheets for healthcare professionals (HCPs), equipping them to better support their clients through recommendations of brandholder products containing Kaneka Ubiquinol™.
Technical enablement: Including stability and formulation guidance in formats beyond traditional softgels.

“Brandholders don’t just need another trending claim – they need an ingredient platform they can build on for years,” says Filip Van hulle, general manager of Kaneka Nutrients Europe.

“Our focus is to help partners connect mitochondrial science to product formats, messaging and go-to-market strategy, backed by the quality and substantiation Kaneka Ubiquinol™ is known for.”

A foundational ingredient for mitochondrial health

Central to mitochondrial health is ubiquinol – a bioactive, bioavailable form of coenzyme Q10 (CoQ10) used within the electron transport chain for cellular energy production and antioxidant activity in the mitochondria of almost all cells.

Kaneka positions ubiquinol not as a single-outcome ingredient but as a foundational bioactive, relevant anywhere that energy demand and oxidative stress intersect, particularly in high-energy tissues such as the heart, brain, skeletal muscle and reproductive cells/gametes.

Key mitochondrial functions of ubiquinol

Why form matters for product performance

A key consideration for brands looking at including CoQ10 in their formulations is that conventional CoQ10 (ubiquinone) must be converted to the active ubiquinol form before it can act as a potent lipid-soluble antioxidant.^1-10 Evidence suggests this conversion may be less efficient with certain health states and advancing age, as well as endogenous CoQ10 levels declining with increasing age, creating a gap for solutions that deliver ubiquinol directly in the bioactive form.^11-15

Stephanie Berglin, nutritionist, herbalist and Kaneka Ubiquinol™ spokesperson, frames this as a practical, portfolio-relevant insight: “If health and longevity is about preserving function, then mitochondrial integrity, and supporting cellular bioenergetics, becomes a foundational consideration as we age.”

A broad, substantiated benefit set – anchored in mitochondrial biology

For brandholders, the value of a foundational ingredient is not just the mechanism of action, but also the versatility of clinically aligned applications and evidence. Kaneka Ubiquinol™ has over 100 studies and more than 45 years of research to support a depth of substantiation for use in:

Energy production for fatigue/tiredness.^6-7
Physical endurance, stamina and exercise recovery.^8-10
Cardiovascular and blood vessel health, including healthy blood lipids/cholesterol support.^16-21
Cognitive and mental function.^22-23
Reproductive and preconception health (male and female).^24-28
Women’s health during reproductive and menopausal years.^29-32
General wellbeing and vitality in ageing individuals, with antioxidant support central to cellular protection.^33-36

Importantly, Kaneka Ubiquinol™ positioning is underpinned by scale of investment and quality track record. Kaneka Corporation is the sole global supplier of Kaneka Ubiquinol™ produced via a unique natural yeast fermentation using meticulous, patented Japanese manufacturing processes, crafted over decades, to produce a structurally identical (bioidentical) ubiquinol to that naturally produced in the body.

Quality and stability as strategic differentiators

Mitochondrial health is increasingly an evidence-driven space, which makes ingredient integrity non-negotiable. Kaneka’s platform explicitly elevates quality and stability as part of brand value, supported by pharmaceutical-level manufacturing standards, certifications and the Kaneka Ubiquinol™ Quality Seal system for on-pack recognition.

Ubiquinol is inherently prone to oxidation, and maintaining stability across manufacturing, distribution and shelf-life is a known technical challenge. In oil-based systems, stability becomes especially dependent on oil selection, formulation design and real-world handling. Kaneka Ubiquinol™ demonstrates high stability across multiple formats including softgels, capsules, tablets, liquids, powders, gummies, gels and functional foods.

For brandholders, this translates into a commercially meaningful promise: delivering the active ingredient in the form and quality stated on the label – throughout shelf-life, and not just “at manufacture”.

Formats and combinations that meet consumers where they are

As mitochondrial health moves from niche to mainstream, formats matter. The market is already expanding into convenient, compliance-friendly delivery systems – particularly where brands are targeting younger prevention-minded consumers as well as mid-life healthy agers.

Kaneka’s format toolkit supports this shift. Alongside traditional delivery options, Kaneka highlights:

Stabilised powder designed for applications requiring alternative formats (e.g. hard capsules, sachets).
Tablets via unique formulation technology, delivering shelf-life stability and evidence-based dosage of 100mg per tablet
Softgel/vegi-cap options including Halal-certified formats in select configurations
Innovation in oil-based formulations where oxidative stability is engineered through oil-phase design – opening new possibilities beyond oxygen exclusion as the default approach

From a combination strategy perspective, mitochondrial health lends itself to stackable product design – where ubiquinol can function as the foundational bioenergetic and antioxidant layer with brands building targeted benefits around it (e.g. women’s health and energy; cardiometabolic and healthy ageing; performance and recovery).

This is the type of formulation logic that helps brands extend a single ingredient investment across multiple SKUs without diluting scientific credibility.

Kaneka Ubiquinol's scientifically proven stability

What to expect at VFE 2026

Kaneka Ubiquinol™ is the Mitochondrial Health Category Sponsor for Vitafoods Europe 2026, using the event to advance both science education and commercial enablement for brandholders.

A centrepiece is the Kaneka Mitochondrial Innovation Forum – a series of 15-minute sessions designed to translate mitochondrial science into actionable insights for brandholders, NPD, formulators and marketers.

Programming themes include the science underpinning mitochondrial function and ubiquinol, key category drivers (longevity, women’s health/menopause, cardiometabolic health, cognition, fertility, energy), innovative formulation considerations, and go-to-market strategy including cross-border e-commerce learnings.

Kaneka Ubiquinol™ will also host the Kaneka Genki VIP Cocktail Session, an invite-only setting intended for deeper discussion with expert speakers and industry leaders working at the frontier of cellular health.

“As category sponsor, Kaneka’s goal is to make mitochondrial health easier to execute commercially without losing scientific integrity,” says Berglin.

“The opportunity is big, but brands win when they pair credible substantiation with formats and messaging that consumers actually understand and adopt,” adds Van hulle.

References